10-Q Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001493152-22-022369`
Period End Date	20220630
Filing Date	20220812
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 76 Cash Flow Statement 78 Stockholders Equity 51

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$17.36M	USD	Point-in-time
Cash	`Cash`	$18.01M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.36M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$380.84K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.37M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$783.46K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$294.43K	USD	Point-in-time
Right-of-use operating lease asset	`OperatingLeaseRightOfUseAsset`	$120.97K	USD	Point-in-time
Right-of-use operating lease asset	`OperatingLeaseRightOfUseAsset`	$176.30K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.92M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.74M	USD	Point-in-time
Goodwill	`Goodwill`	$1.59M	USD	Point-in-time
Goodwill	`Goodwill`	$1.56M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$9.20M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$8.98M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Total assets	`Assets`	$28.57M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Total assets	`Assets`	$26.72M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$754.30K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$683.39K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.29M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	651,921.00	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.05M	shares	Point-in-time
Current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityCurrent`	$107.44K	USD	Point-in-time
Current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityCurrent`	$111.10K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.05M	shares	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	651,921.00	shares	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$455.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.32M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.08M	USD	Point-in-time
Non-current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityNoncurrent`	$9.87K	USD	Point-in-time
Non-current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityNoncurrent`	$68.86K	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilities`	$1.61M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilities`	$1.63M	USD	Point-in-time
Warrant liability	`WarrantLiabilitiesNoncurrent`	$2.00M	USD	Point-in-time
Warrant liability	`WarrantLiabilitiesNoncurrent`	$653.67K	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$3.64M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.97M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable non-controlling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$637.84K	USD	Point-in-time
Redeemable non-controlling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Series C redeemable preferred stock, $0.01 par value, 100,000 shares authorized, and 52,684.548 and 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$527.00	USD	Point-in-time
Series C redeemable preferred stock, $0.01 par value, 100,000 shares authorized, and 52,684.548 and 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Total mezzanine equity	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$638.37K	USD	Point-in-time
Total mezzanine equity	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	-	USD	Point-in-time
Preferred stock, $0.01 par value, 20,000,000 shares authorized; Series B preferred stock, $0.01 par value, 3,600,000 shares authorized, 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value, 20,000,000 shares authorized; Series B preferred stock, $0.01 par value, 3,600,000 shares authorized, 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 1,054,043 and 651,921 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$6.52K	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 1,054,043 and 651,921 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$10.54K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$83.07M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$90.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-60.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-68.05M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.80K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-223.11K	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$18.82M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$24.44M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$21.97M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$18.99M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$22.31M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$3.42M	USD	Point-in-time
Total liabilities, mezzanine equity, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$26.72M	USD	Point-in-time
Total liabilities, mezzanine equity, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$28.57M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$2.50M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.27M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.74M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.31M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.08M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.12M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.08M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$879.84K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$85.50K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$174.02K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$310.66K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$154.77K	USD	2 Qtrs
Total operating expenses	`OperatingCostsAndExpenses`	$9.50M	USD	2 Qtrs
Total operating expenses	`OperatingCostsAndExpenses`	$10.13M	USD	2 Qtrs
Total operating expenses	`OperatingCostsAndExpenses`	$4.71M	USD	1 Quarter
Total operating expenses	`OperatingCostsAndExpenses`	$3.36M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-9.50M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-10.13M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.36M	USD	1 Quarter
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	$298.71K	USD	2 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	-	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-6.27M	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-2.46M	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-1.97M	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-2.25M	USD	2 Qtrs
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-53.00K	USD	2 Qtrs
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-53.00K	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	$4.82K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.82K	USD	2 Qtrs
Interest expense	`InterestExpense`	$4.81K	USD	2 Qtrs
Interest expense	`InterestExpense`	$668.00	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.19M	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.45M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.92M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$5.97M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.16M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.31M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	$7.81K	USD	1 Quarter
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	$7.81K	USD	2 Qtrs
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	-	USD	2 Qtrs
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	$-73.99K	USD	2 Qtrs
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	-	USD	2 Qtrs
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	$-73.99K	USD	1 Quarter
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	-	USD	1 Quarter
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.40M	USD	2 Qtrs
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-908.29K	USD	1 Quarter
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.87M	USD	1 Quarter
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.16M	USD	2 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$88.71K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.26K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-192.31K	USD	2 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-281.01K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.47K	USD	2 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.74K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.16M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.15M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-7.59M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-941.55K	USD	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-2.73	USD	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-10.62	USD	2 Qtrs
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-2.13	USD	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-7.78	USD	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	1.05M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	951,193.00	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	426,883.00	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	391,516.00	shares	2 Qtrs

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.16M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.31M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-6.27M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.46M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.97M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.25M	USD	2 Qtrs
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-53.00K	USD	2 Qtrs
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-53.00K	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.45M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.34M	USD	2 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	$298.71K	USD	2 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	-	USD	2 Qtrs
Amortization of right-of-use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$68.91K	USD	2 Qtrs
Amortization of right-of-use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	-	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$174.02K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$42.19K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$84.38K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$310.66K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$43.31K	USD	1 Quarter
Depreciation expense	`Depreciation`	$70.39K	USD	2 Qtrs
Depreciation expense	`Depreciation`	-	USD	1 Quarter
Depreciation expense	`Depreciation`	-	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.03M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$190.76K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$486.27K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-187.90K	USD	2 Qtrs
Right-of-use operating lease liability	`IncreaseDecreaseInRightOfUseLeaseLiability`	$76.69K	USD	2 Qtrs
Right-of-use operating lease liability	`IncreaseDecreaseInRightOfUseLeaseLiability`	-	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.18M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.13M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$559.40K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Purchase of license agreement	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Purchase of license agreement	`PaymentsToAcquireIntangibleAssets`	$675.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-675.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-559.40K	USD	2 Qtrs
Proceeds from sale of common stock and warrants, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$9.40M	USD	2 Qtrs
Proceeds from sale of common stock and warrants, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$21.61M	USD	2 Qtrs
Proceeds from the sale of redeemable non-controlling interest, net of offering costs (see Note 6)	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Proceeds from the sale of redeemable non-controlling interest, net of offering costs (see Note 6)	`ProceedsFromMinorityShareholders`	$958.04K	USD	2 Qtrs
Proceeds from warrant exercises	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from warrant exercises	`ProceedsFromWarrantExercises`	$3.29M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.36M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.90M	USD	2 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-1.05K	USD	2 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-9.43K	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$652.95K	USD	2 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$19.04M	USD	2 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.36M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$18.01M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.62M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.36M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$18.01M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.62M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$4.81K	USD	2 Qtrs
Warrants issued in conjunction with common stock issuance	`WarrantsIssuedInConjunctionWithNotesPayable`	-	USD	2 Qtrs
Warrants issued in conjunction with common stock issuance	`WarrantsIssuedInConjunctionWithNotesPayable`	$3.60M	USD	2 Qtrs
Issuance of embedded derivative	`IssuanceOfEmbeddedDerivative`	-	USD	2 Qtrs
Issuance of embedded derivative	`IssuanceOfEmbeddedDerivative`	$402.00K	USD	2 Qtrs
Issuance of redeemable non-controlling Series C preferred stock	`IssuanceOfRedeemableNoncontrollingSeriesCPreferredStock`	-	USD	2 Qtrs
Issuance of redeemable non-controlling Series C preferred stock	`IssuanceOfRedeemableNoncontrollingSeriesCPreferredStock`	$527.00	USD	2 Qtrs
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$7.81K	USD	2 Qtrs
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$-7.81K	USD	1 Quarter
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	-	USD	2 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	-	USD	2 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$73.99K	USD	2 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$-73.99K	USD	1 Quarter

Stockholders Equity 51 line items

Line Item	Tag	Value	Unit	Period
Redeemable noncontrolling interest embedded derivative	`RedeemableNoncontrollingInterestEmbeddedDerivative`	$402.00K	USD	2 Qtrs
Redeemable noncontrolling interest issuance costs	`RedeemableNoncontrollingInterestIssuanceCosts`	$41.96K	USD	2 Qtrs
Beginning balance, value	`StockholdersEquity`	$18.82M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$24.44M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$21.97M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.99M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$22.31M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$3.42M	USD	Point-in-time
January 2021 registered direct offering	`StockIssuedDuringPeriodValueIssuedDirectOfferingNet`	$4.62M	USD	1 Quarter
February registered direct offering	`StockIssuedDuringPeriodValueIssuedDirectOfferingNetOne`	$5.80M	USD	1 Quarter
February registered direct offering	`StockIssuedDuringPeriodValueIssuedDirectOfferingNetOne`	$7.02M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$750.93K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$677.54K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.59M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$768.62K	USD	1 Quarter
Induced conversion of stock options into restricted stock awards	`AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium`	$298.71K	USD	1 Quarter
Conversion of Series B Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$17.93K	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$3.27M	USD	1 Quarter
Foreign currency translation gain loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$88.71K	USD	1 Quarter
Foreign currency translation gain loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.26K	USD	1 Quarter
Foreign currency translation gain loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-192.31K	USD	2 Qtrs
Foreign currency translation gain loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-281.01K	USD	1 Quarter
Foreign currency translation gain loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.47K	USD	2 Qtrs
Foreign currency translation gain loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.74K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.16M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.31M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Conversion of stock options into restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Conversion of stock options into restricted stock, shares	`StockIssuedDuringPeriodSharesRestrictedStockAwardGross`	2,122.00	shares	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	1 Quarter
Conversion of RSAs into common shares	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	1 Quarter
Conversion of RSAs into common shares	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	1 Quarter
Redeemable non-controlling interest, net of $402,000 embedded derivative and net of issuance costs of $41,962	`RedeemableNoncontrollingInterestEmbeddedDerivativeAndNetOfIssuanceCosts`	-	USD	1 Quarter
Redeemable noncontrolling interest, net of $402,000 embedded derivative and net of issuance costs of $41,962, shares	`RedeemableNoncontrollingInterestEmbeddedDerivativeAndNetOfIssuanceCostsShares`	556,038.00	shares	2 Qtrs
Issuance of redeemable non-controlling Series C preferred stock	`IssuanceOfRedeemableNoncontrollingSeriesPreferredStock`	$-527.00	USD	1 Quarter
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$7.81K	USD	2 Qtrs
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$-7.81K	USD	1 Quarter
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	-	USD	2 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	-	USD	2 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$73.99K	USD	2 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$-73.99K	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$18.82M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$24.44M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$21.97M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.99M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$22.31M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$3.42M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.